Retension Pharmaceuticals, Inc.'s (NASDAQ:RTSN) Quiet Period To End on November 18th
MarketBeat
Retension Pharmaceuticals' (NASDAQ:RTSN - Get Free Report) quiet period is set to end on Wednesday, November 18th. Retension Pharmaceuticals had issued 3,750,000 shares in its public offering on October 9th. The total size of the offering was $45,000,000 based on an initial share price of $12.00. During Retension Pharmaceuticals' quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
NASDAQ:RTSN